,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2011-04-25 09:17:00,"Colgate-Palmolive ( CL ), the world leader in oral care, is expected to release Q1 2011 earnings on April 28.",0.19492493569850922,0.006599805783480406,0.7984752655029297,neutral,0.18832513689994812
1,2011-04-25 09:17:00,Here we highlight two key trends that investors should keep an eye on - how margins have trended over the past quarter and the outlook for market share.,0.30306369066238403,0.014490491710603237,0.6824458241462708,neutral,0.2885732054710388
2,2011-04-25 09:17:00,"Colgate competes with other leading personal care companies such as Procter & Gamble ( PG ), Unilever ( UL ) and Kimberly-Clark ( KMB ).",0.9190173149108887,0.017453797161579132,0.06352891027927399,positive,0.9015635251998901
3,2011-04-25 09:17:00,"We value Colgate-Palmolive stock with a $88.80 price estimate , a roughly 10% premium to market price.",0.17543664574623108,0.009016691707074642,0.8155466914176941,neutral,0.16641995310783386
4,2011-04-25 09:17:00,"Apart from oral care products, Colgate-Palmolive also makes personal care and home care products like soaps, shampoos, and fabric conditioners.",0.017935404554009438,0.007601698394864798,0.9744628667831421,neutral,0.010333705693483353
5,2011-04-25 09:17:00,Colgate-Palmolive closed 2010 with 3% volume growth at flat pricing.,0.3545597493648529,0.03380397707223892,0.611636221408844,neutral,0.3207557797431946
6,2011-04-25 09:17:00,The company stood still on pricing while other leading players such as P&G and Unilever withdrew promotions and actually raised prices to combat rising input (commodity) costs.,0.41729286313056946,0.3482450842857361,0.23446209728717804,positive,0.06904777884483337
7,2011-04-25 09:17:00,"While a volume-driven growth strategy might put Colgate at an advantage in the lower-income but high-growth emerging markets, we fear that persistent inflation could erode profit margins.",0.2452346235513687,0.7083690166473389,0.04639633372426033,negative,-0.46313440799713135
8,2011-04-25 09:17:00,"We haven't seen price increases in the past quarter, so much rests on maintaining operating expenses to sustain EBITDA margins.",0.5150982141494751,0.09975583106279373,0.3851459324359894,positive,0.41534239053726196
9,2011-04-25 09:17:00,You can drag the trend line in the interactive chart below to see the impact of various EBITDA margin scenarios on Colgate-Palmolive's stock value.,0.00978575274348259,0.016746295616030693,0.9734679460525513,neutral,-0.006960542872548103
10,2011-04-25 09:17:00,"Should Colgate-Palmolive choose to maintain its volume-driven growth strategy, it must realize significant market share gains to offset lower profit margins.",0.9475423097610474,0.01686931774020195,0.035588402301073074,positive,0.9306730031967163
11,2011-04-25 09:17:00,"It is important to note that a single quarter is too short to comment on the outcome of this strategy, and investors should look at the trend emerging over the past few quarters to gain a more complete picture.",0.09399377554655075,0.01127893291413784,0.8947272896766663,neutral,0.08271484076976776
12,2011-04-25 09:17:00,What Else Should be on the Radar?,0.09575758129358292,0.11626676470041275,0.7879756689071655,neutral,-0.020509183406829834
13,2011-04-25 09:17:00,"Restructuring costs and integration expenses : On March 23, Colgate-Palmolive agreed to buy Unilever's Sanex brand of personal care products for roughly $954 million and sell its laundry detergent business in Colombia to Unilever for $215 million.",0.2078920602798462,0.10034224390983582,0.6917656660079956,neutral,0.10754981637001038
14,2011-04-25 09:17:00,"While the deal promises to strengthen Colgate's personal care business in Europe, we're keeping a watch on the merger-related expenses and the post-merger integration costs yet to be incurred.",0.6241903901100159,0.029241502285003662,0.3465680778026581,positive,0.5949488878250122
15,2011-04-25 09:17:00,"See our complete analysis of Colgate-Palmolive's stock here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.009463774971663952,0.01866774819791317,0.9718685150146484,neutral,-0.009203973226249218
